Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Merck
Medtronic
Baxter
McKesson
Colorcon

Last Updated: April 8, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Fispemifene


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Fispemifene?

Fispemifene is an investigational drug.

There have been 4 clinical trials for Fispemifene. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2015.

The most common disease conditions in clinical trials are Hypogonadism, Erectile Dysfunction, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are QuatRx Pharmaceuticals Company, Hormos Medical, and NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.).

There are thirteen US patents protecting this investigational drug and one hundred and thirty-eight international patents.

Recent Clinical Trials for Fispemifene
TitleSponsorPhase
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal MenNexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)Phase 2
Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid TherapyQuatRx Pharmaceuticals CompanyPhase 2
Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 InhibitorsHormos MedicalPhase 2

See all Fispemifene clinical trials

Clinical Trial Summary for Fispemifene

Top disease conditions for Fispemifene
Top clinical trial sponsors for Fispemifene

See all Fispemifene clinical trials

US Patents for Fispemifene

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fispemifene   Start Trial Triphenylalkene derivatives and their use as selective estrogen receptor modulators Hormos Medical Oy Ltd (Turku, FI)   Start Trial
Fispemifene   Start Trial Triphenylalkene derivatives and their use as selective estrogen receptor modulators Hormos Medical Oy LTD (Turku, FI)   Start Trial
Fispemifene   Start Trial Method for the preparation of 2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy]ethoxy}ethanol and its isomers Hormos Medical Corporation (Turku, FI)   Start Trial
Fispemifene   Start Trial Methods for the preparation of fispemifene from ospemifene Hormos Medical Ltd. (Turku, FI)   Start Trial
Fispemifene   Start Trial Method for the preparation of therapeutically valuable triphenylbutene derivatives Hormos Medical Ltd. (Turku, FI)   Start Trial
Fispemifene   Start Trial Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors AEterna Zentaris GmbH (Frankfurt, DE)   Start Trial
Fispemifene   Start Trial Method for the preparation of therapeutically valuable triphenylbutene derivatives Hormos Medical Ltd. (Turku, FI)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fispemifene

Drugname Country Document Number Estimated Expiration Related US Patent
Fispemifene Austria 317378 2019-11-16   Start Trial
Fispemifene Australia 1150301 2019-11-16   Start Trial
Fispemifene Australia 778296 2019-11-16   Start Trial
Fispemifene Bulgaria 106413 2019-11-16   Start Trial
Fispemifene Bulgaria 65853 2019-11-16   Start Trial
Fispemifene Brazil 0014901 2019-11-16   Start Trial
Fispemifene Brazil PI0014901 2019-11-16   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Merck
Harvard Business School
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.